TAZIDIME Detail

Drug Name(s):
TAZIDIME

FDA Application No.:
NDA 062655

Active Ingredient(s):
CEFTAZIDIME

Company:
LILLY

Original Approval or Tentative Approval Date:
November 19, 1985

Products on Application NDA 062655:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
CEFTAZIDIME	2GM/VIAL	INJECTABLE; INJECTION	Discontinued	none

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Resources

Medical Dictionary

Drug Information

Events

«	December 2008
S	M	T	W	T	F	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Job search

Find jobs in healthcare or get job search tips

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

We comply with the HONcode standard for health trust worthy information:
verify here.

Links to Site

last updated on 12-01-2008

TAZIDIME Detail

Hot Topics

Sponsored Links

Recall Notices

Action Alerts

Most Recent Content

Active forum topics

Poll

Subscribe to our feed